milrinone has been researched along with Recrudescence in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Attempts to reverse cerebral vasospasm (CVS) after aneurysmal subarachnoid hemorrhage (aSAH) rely on a limited number of treatments." | 5.35 | Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. ( Cholley, BP; Fraticelli, AT; Losser, MR; Payen, D; Saint Maurice, JP, 2008) |
| "Attempts to reverse cerebral vasospasm (CVS) after aneurysmal subarachnoid hemorrhage (aSAH) rely on a limited number of treatments." | 1.35 | Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. ( Cholley, BP; Fraticelli, AT; Losser, MR; Payen, D; Saint Maurice, JP, 2008) |
| "Their mitral regurgitation (MR) is a result of left ventricular (LV) geometrical distortion." | 1.33 | Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. ( Bolling, SF; Geltz, A; Spoor, MT, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lam, H | 1 |
| Nguyen, T | 1 |
| Austin, T | 1 |
| Spoor, MT | 1 |
| Geltz, A | 1 |
| Bolling, SF | 1 |
| Fraticelli, AT | 1 |
| Cholley, BP | 1 |
| Losser, MR | 1 |
| Saint Maurice, JP | 1 |
| Payen, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Intra-arterial Vasospasm Trial(iVAST)- A Multi-center Randomized Study[NCT01996436] | Phase 4 | 330 participants (Anticipated) | Interventional | 2016-08-29 | Recruiting | ||
| Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage[NCT02712788] | Phase 2 | 4 participants (Actual) | Interventional | 2016-04-18 | Terminated (stopped due to Completion not feasible due to lack of eligible subjects.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Reported as number for each subject and then will look statistically to see if there is a difference between the active arm and the placebo arm. The Modified Rankin scale is Scored as follows: 0 = No symptoms, 1 = No significant disability. Able to carry out all usual activities, despite some symptoms, 2 = Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities, 3 = Moderate disability. Requires some help, but able to walk unassisted, 4 = Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted, 5 = Severe disability. Requires constant nursing care and attention, bedridden, incontinent, 6 = Death. Higher scores indicate worse outcome. (NCT02712788)
Timeframe: 6 months
| Intervention | score on a scale (Mean) |
|---|---|
| Placebo | 1.5 |
Reported as number for each subject and then will look statistically to see if there is a difference between the active arm and the placebo arm. THe Modified Rankin Scale is Scored as follows: 0 = No symptoms, 1 = No significant disability. Able to carry out all usual activities, despite some symptoms, 2 = Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities, 3 = Moderate disability. Requires some help, but able to walk unassisted, 4 = Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted, 5 = Severe disability. Requires constant nursing care and attention, bedridden, incontinent, 6 = Death. Higher scores indicate worse outcome. (NCT02712788)
Timeframe: 12 months
| Intervention | score on a scale (Mean) |
|---|---|
| Placebo | 2 |
3 other studies available for milrinone and Recrudescence
| Article | Year |
|---|---|
Recurrent cardiomyopathy from recurrent pheochromocytoma in a pediatric patient.
Topics: Adrenal Gland Neoplasms; Cardiomyopathies; Cardiotonic Agents; Child; Humans; Male; Milrinone; Pheoc | 2014 |
Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiomyopathy, Dilated; Combined Modality | 2006 |
Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Angioplasty; Cerebral Angiography; Female; Heart Rate; Humans; Infusions, Intravenous; | 2008 |
Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Angioplasty; Cerebral Angiography; Female; Heart Rate; Humans; Infusions, Intravenous; | 2008 |
Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Angioplasty; Cerebral Angiography; Female; Heart Rate; Humans; Infusions, Intravenous; | 2008 |
Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Angioplasty; Cerebral Angiography; Female; Heart Rate; Humans; Infusions, Intravenous; | 2008 |